Globe Newswire
Versailles, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- Frontier Nursing University (FNU) and the Campion Fund announced plans for a conference focused on the nation’s maternal mortality crisis. “Reducing Maternal Mortality: Strategies That Work!” will be held on Thursday, September 19, on the FNU campus in Versailles, Kentucky. Capacity is limited to 100 spots for the in-person conference, with an additional 300 spots available for online attendees.
This... (continue reading...)
Please find enclosed the presentation of Golden Ocean Group Limited’s first quarter 2024 results for today’s webcast / conference call at 15:00 CEST.
Attend by Webcast:
Use the follow link prior to the webcast:
Attend by Conference Call:
Participants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered.
A Q&A... (continue reading...)
Legend Biotech obtains license to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its non-viral engineered pipeline portfolio across a variety of cell types including T cells, Gamma-Delta T cells and NK Cells.
ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and... (continue reading...)
DALLAS, May 22, 2024 (GLOBE NEWSWIRE) -- Tricolor today announced its fourth social bond, a $277 million issuance to empower underserved, low-income Hispanic communities with access to affordable financing for their vital transportation needs that ultimately unlocks a path to mainstream financing.
Tricolor is an award-winning fintech innovator that leverages artificial intelligence (AI) to successfully underwrite and extend affordable loans to credit invisible... (continue reading...)
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Michael Raab, President and CEO, and Justin Renz, chief financial and operations officer, will participate in a fireside chat at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5,... (continue reading...)
More Globe Newswire
View Older Stories-
Fraser Institute News Release: Government funding for independent schools saves British Columbia taxpayers millions every year
-
CDT Environmental Technology Investment Holdings Limited Establishes Partnership with Fortune 500 Company's Subsidiary to Jointly Bid for Large-Scale Sewage Treatment Facility in Hengqin, China
-
CDT Environmental Technology Investment Holdings Limited Establishes Partnership with Fortune 500 Company's Subsidiary to Jointly Bid for Large-Scale Sewage Treatment Facility in Hengqin, China
-
Liberty Military Housing Named Among Best Places to Work in Commercial Real Estate by Globe St.
-
OPTIZMO™ Partners as Official Content Sponsor for LinkUnite IV
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
-
Soleno Therapeutics to Participate in Upcoming Investor Conferences
-
Yocan Unveils the Yocan Kodo Animal Series
-
Formation Minerals, Inc. Announces Opportunistic Divestiture of Assets
-
Catalogic Software's Latest DPX Ensures Flexible Immutability to Safeguard Data
-
Avatier Identity & Access Management for IBM i (Formerly iSeries) Environments
-
ABM to Announce Second Quarter 2024 Financial Results
-
Infinidat Launches Next-Generation InfiniBox® G4 Family of Cyber Secure Storage Arrays, Expands InfiniVerse® Platform for Infrastructure Consumption Services
-
For the Third Year in a Row, StorONE is Named One of the 50 Coolest Software-Defined Storage Vendors in the 2024 CRN® Storage 100
-
Arctic Semiconductor Announces 3GPP Compliant Platform for 5G Private Networks Featuring Products from Skyworks and Synergy
-
Arq Publishes its Inaugural ESG Overview
-
Alignment Healthcare to Present at William Blair's 44th Annual Growth Stock Conference
-
TimeProvider® 4100 Grandmaster Version 2.4 Firmware Offers Embedded BlueSky™ Firewall Technology to Detect Security Threats
-
Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer
-
Noema Pharma Announces First Patient Dosed in Phase 2a Study of NOE-115, a First-In-Class Investigational Therapy for the Treatment of Vasomotor Symptoms and Additional Symptoms Associated with Menopa
-
All resolutions approved at the 2024 STMicroelectronics' Annual General Meeting of Shareholders
-
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
-
Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness
-
BioVie’s Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients
-
Heartland BancCorp Elects Diana L. Turoff, CPA to Board
-
Lasso Security Launches Contextual Data Protection Tool for GenAI Applications
-
RedBird Capital and Weatherford Capital Announce “Collegiate Athletic Solutions,” a Capital Solutions Platform for University Athletic Departments
-
First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To Treat Hypercholesterolem
-
Gevulot Sets Firestarter Mainnet Launch on July 15, Explains ZK Endgame Approach
-
GDEV Inc. to Announce First Quarter 2024 Financial Results on May 28, 2024
-
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
-
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
-
NeurAxis Reports First Quarter 2024 Financial Results
-
Huntress Releases 2024 Cyber Threat Report, Highlights Increased Targeting of Healthcare and Other Vital Industries
-
Brooklyn Law School Announces New Fagen Professorship
-
FuelCell Energy Announces Second Quarter of Fiscal 2024 Results Conference Call on June 10, 2024 at 10 A.M. Eastern Time
-
Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024
-
Team BlueHalo Demonstrates Integrated Backend Mission Services for Space Force’s SCAR Program
-
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
-
The Vita Coco Company to Participate in the William Blair Growth Stock Conference
-
HII to Participate in Bernstein’s 40th Annual Strategic Decisions Conference on May 29
-
Cities in Florida Top U.S. Charts in Freelancer Population and Revenue Growth, According to Fiverr’s 7th Annual Freelance Economic Impact Report
-
Luke Henderson Appointed Managing Director, Investor Relations and Capital Formation at Fengate Asset Management
-
Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors
-
Ealixir Inc. Announces Engagement of RBSM LLP as New Auditor
-
Summit Racing Introduces the Summit Racing Equipment Rewards Program
-
NV5 to Host 2024 Investor Day: The Nexus of Engineering and Technology on Thursday, July 25th
-
Dayforce Delivers Dayforce® Flex Work
-
Ingage Welcomes Brian Gottlieb to its Board of Directors
-
Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024